Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00234559|
Recruitment Status : Withdrawn (Study terminated due to no subject enrollment.)
First Posted : October 7, 2005
Last Update Posted : August 21, 2013
The purpose of this study is to determine:
- If vacuum assisted closure (VAC®) therapy results in altered proteomic expression of angiogenic markers compared to moist wound therapy.
- If VAC® therapy results in increased angiogenesis compared to moist wound therapy.
|Condition or disease||Intervention/treatment||Phase|
|Wounds||Device: VAC® Therapy System||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomized Controlled Study Comparing Vacuum Assisted Closure® Therapy to Moist Wound Therapy in Angiogenesis|
|Study Start Date :||September 2005|
|Actual Primary Completion Date :||August 2007|
|Actual Study Completion Date :||August 2007|
- Altered proteomic expression evaluated by angiogenic markers using biomolecular assays of biopsy samples at Day 0, Day 3, Day 7, Day 21, and Day 28
- Increased angiogenesis of the lower extremity wound will be quantified using the MicroScan™ (video microscope) at Day 0, Day 3, Day 7, Day 21, Day 28, Day 42, and at follow up visit.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00234559
|Principal Investigator:||Jeffrey A Niezgoda, M.D.||St. Luke's Medical Center of Aurora Health Care|